Association Between Prenatal Acetaminophen Exposure and Future Risk of Attention Deficit/Hyperactivity Disorder in Children

Annals of Pharmacotherapy

Volumn 49, Issue 12, 2015, Pages 1357-1361

  Hoover, Rebecca M ^a   Hayes, V Autumn Gombert ^a   Erramouspe, John ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

acetaminophen; attention deficit hyperactivity disorder; pregnancy

Indexed keywords

PARACETAMOL; ANALGESIC AGENT;

AGGRESSION; ATTENTION DEFICIT DISORDER; CHILD BEHAVIOR CHECKLIST; DRUG EFFECT; FEVER; HUMAN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SELF REPORT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; ENVIRONMENTAL EXPOSURE; FEMALE; PRESCHOOL CHILD; PSYCHOLOGY; QUESTIONNAIRE; RISK;

ACETAMINOPHEN; ANALGESICS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MATERNAL EXPOSURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK; SURVEYS AND QUESTIONNAIRES;

EID: 84947280861     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028015606469     Document Type: Review

References (17)

1. M.M.WerlerA.A.MitchellS.Hernandez-DiazM.A.Honein. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol. 2005;193:771-777.
2. Food and Drug Administration, Department of Health and Human Services. Drug Safety Communications. FDA has reviewed possible risks of pain medication during pregnancy. January92015. http://www.fda.gov/downloads/Drugs/DrugSafety/UCM429119.pdf. Accessed July 14, 2015.
3. G.G.BriggsR.K.FreemanS.J.Yaffe. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 9th ed. Baltimore, MD: Williams & Wilkins; 2011.
4. H.HaibachJ.E.AkhterM.S.MuscatoP.L.CaryM.F.Hoffmann. Acetaminophen overdose with fetal demise. Am J Clin Pathol. 1984;82:240-242.
5. P.-H.WangM.-J.YangW.-L.LeeH.-T.ChaoM.-L.YangJ.-H.Hung. Acetaminophen poisoning in late pregnancy. A case report. J Reprod Med. 1997;42:367-371.
6. K.ThieleT.KesslerP.ArckA.ErhardtG.Tiegs. Acetaminophen and pregnancy: short- and long-term consequences for mother and child. J Reprod Immunol. 2013;97:128-139.
7. C.A.FryeE.BoG.Calamandrei. Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems. J Neuroendocrinol. 2012;24:144-159.
8. K.L.Howdeshell. A model of the development of the brain as a construct of the thyroid system. Environ Health Perspect. 2002;110(suppl 3):337-348.
9. D.R.RubinowP.J.Schmidt. Androgens, brain, and behavior. Am J Psychiatry. 1996;153:974-984.
10. G.PolanczykM.S.de LimaB.L.HortaJ.BiedermanL.A.Rohde. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164:942-948.
11. A.P.StreissguthR.P.TrederH.M.Barr. Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements. Teratology. 1987;35:211-219.
12. R.E.BrandlistuenE.YstromI.NulmanG.KorenH.Nordeng. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol. 2013;42:1702-1713.
13. Z.LiewB.RitzC.RebordosaP.C.LeeJ.Olsen. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014;168:313-320.
14. J.M.ThompsonK.E.WaldieC.R.WallR.MurphyE.A.Mitchell; ABC Study Group. Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years. PLoS One. 2014;9:e108210.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
16. Subcommittee on Attention-Deficit/Hyperactivity Disorder; Steering Committee on Quality Improvement and Management, M.WolraichL.BrownR.T.Brown. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128:1007-1022.
17. Food and Drug Administration, Department of Health and Human Services. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Fed Regist. 2014;233:72063-72103.